Last reviewed · How we verify
Application of Onco-Neutre cream
Application of Onco-Neutre cream is a Small molecule drug developed by Hospices Civils de Lyon. It is currently in Phase 1 development.
At a glance
| Generic name | Application of Onco-Neutre cream |
|---|---|
| Sponsor | Hospices Civils de Lyon |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer Therapies (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Application of Onco-Neutre cream CI brief — competitive landscape report
- Application of Onco-Neutre cream updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI
Frequently asked questions about Application of Onco-Neutre cream
What is Application of Onco-Neutre cream?
Application of Onco-Neutre cream is a Small molecule drug developed by Hospices Civils de Lyon.
Who makes Application of Onco-Neutre cream?
Application of Onco-Neutre cream is developed by Hospices Civils de Lyon (see full Hospices Civils de Lyon pipeline at /company/hospices-civils-de-lyon).
What development phase is Application of Onco-Neutre cream in?
Application of Onco-Neutre cream is in Phase 1.